Trade Summary

2 days ago, Ron-Bigger Shulamit, serving as Chief Operating Officer at Aktis Oncology, Inc. (AKTS), sold 50,000 shares at $27.75 per share, for a total transaction value of $1,387,557.78.

This sale represents a 100.00% decrease in Ron-Bigger Shulamit's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 at 6:11 AM ET, 2 days after the trade was made.

Aktis Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.